Mode
Text Size
Log in / Sign up
N/A N=219

HIV-Tb Confections Among HIV Patients

HIV

Enrolled (actual)
219
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: Prevalence of HIV/Tb. co Infections Among Patients of HIV Enrolled at ART Center. — 48 participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Pediatric, Adult, Older Adult · 5+ yrs
Sex
All
Sponsor
Singh, Ranjan Kumar, M.D.
Primary completion
May 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Prevalence of HIV/Tb. co Infections Among Patients of HIV Enrolled at ART Center.
48
SECONDARY
Comparing CD4+ T Cell Count in HIV-Tb. and HIV Cases.
314.63; 254.29 <0.049 sig

Summary

A cross sectional study would be done for prevalence of HIV-Tb. co infection among patients of HIV enrolled at ART centre, Khagaria, India, during June' 2015 to May' 2016. A comparative study of CD4 (cluster of differentiation 4) T cell count among HIV-Tb. co infected patient and HIV patients would be taken in account.

Eligibility Criteria

Inclusion Criteria

  • Patients of HIV+ enrolled ART centre

Exclusion Criteria

  • Lost to follow up patients (LFU)
  • Patients died before the treatment started
  • Children below 5 years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02964767). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search